MedTrace Logo

Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels

NCT00249249 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 830

Last updated 2010-01-12

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the efficacy of pitavastatin with that of atorvastatin.

Conditions

Interventions

DRUG

Pitavastatin

DRUG

Atorvastatin

Sponsors & Collaborators

  • Kowa Research Europe

    lead INDUSTRY

Principal Investigators

  • Dragos Budinski, Med Dr. · Kowa Research Europe

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Completion
2006-11-30

Countries

  • Denmark
  • Finland
  • Germany
  • India
  • Israel
  • Italy
  • Netherlands
  • Norway
  • Poland
  • Russia
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00249249 on ClinicalTrials.gov